The University of Southampton
University of Southampton Institutional Repository

Humans of AI3SD: Jules Tilly

Humans of AI3SD: Jules Tilly
Humans of AI3SD: Jules Tilly
This interview forms part of our Humans of AI3SD Series.

In this Humans of AI4SD interview he discusses his varied career, life as a PhD researcher in a startup, the challenges of working with quantum systems and his advice for early career researchers.
AI3SD, Interview
34
University of Southampton
Tilly, Jules
885d18cb-c880-4643-9d6f-0adf44a968a7
Pauli, Michelle
ba2e52e9-984d-47c6-b32b-c6ff10db9542
Frey, Jeremy G.
ba60c559-c4af-44f1-87e6-ce69819bf23f
Kanza, Samantha
b73bcf34-3ff8-4691-bd09-aa657dcff420
Niranjan, Mahesan
5cbaeea8-7288-4b55-a89c-c43d212ddd4f
Tilly, Jules
885d18cb-c880-4643-9d6f-0adf44a968a7
Pauli, Michelle
ba2e52e9-984d-47c6-b32b-c6ff10db9542
Frey, Jeremy G.
ba60c559-c4af-44f1-87e6-ce69819bf23f
Kanza, Samantha
b73bcf34-3ff8-4691-bd09-aa657dcff420
Niranjan, Mahesan
5cbaeea8-7288-4b55-a89c-c43d212ddd4f

Tilly, Jules and Pauli, Michelle , Frey, Jeremy G., Kanza, Samantha and Niranjan, Mahesan (eds.) (2022) Humans of AI3SD: Jules Tilly (Humans-of-AI3SD, 34) University of Southampton 7pp. (doi:10.5258/SOTON/AI3SD0231).

Record type: Monograph (Project Report)

Abstract

This interview forms part of our Humans of AI3SD Series.

In this Humans of AI4SD interview he discusses his varied career, life as a PhD researcher in a startup, the challenges of working with quantum systems and his advice for early career researchers.

Text
Humans_of_AI3SD_Interview-34_JT - Version of Record
Available under License Creative Commons Attribution.
Download (270kB)

More information

Published date: 11 August 2022
Additional Information: Jules Tilly specialises in developing quantum machine learning methods for drug discovery with a focus on optimising algorithm implementation on current / NISQ Quantum Computers. He is a Quantum Research Scientist at Rahko, and is currently completing his PhD at UCL. Prior to this, Jules worked for 6+ years in �nancial services acting as regulatory and strategic advisor for top global investment banks. He holds degrees in Mathematics, Quantum Physics, Law, Economics, Finance and Public Policy. Rahko was acquired by Odyssey Therapeutics, a biotech company pioneering next generation precision immunomodulators and oncology medicines. Read more about Odyssey's mission here [https://odysseytx.com/]
Keywords: AI3SD, Interview

Identifiers

Local EPrints ID: 469315
URI: http://eprints.soton.ac.uk/id/eprint/469315
PURE UUID: 3b375a2f-b07d-4768-a5a8-e57c1eee60f6
ORCID for Jeremy G. Frey: ORCID iD orcid.org/0000-0003-0842-4302
ORCID for Samantha Kanza: ORCID iD orcid.org/0000-0002-4831-9489
ORCID for Mahesan Niranjan: ORCID iD orcid.org/0000-0001-7021-140X

Catalogue record

Date deposited: 13 Sep 2022 16:41
Last modified: 17 Mar 2024 03:52

Export record

Altmetrics

Contributors

Author: Jules Tilly
Author: Michelle Pauli
Editor: Jeremy G. Frey ORCID iD
Editor: Samantha Kanza ORCID iD
Editor: Mahesan Niranjan ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×